A detailed history of En Rich Financial Partners LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, En Rich Financial Partners LLC holds 42 shares of LLY stock, worth $37,720. This represents 0.01% of its overall portfolio holdings.

Number of Shares
42
Holding current value
$37,720
% of portfolio
0.01%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 02, 2024

BUY
$592.2 - $792.28 $24,872 - $33,275
42 New
42 $32.8 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $853B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track En Rich Financial Partners LLC Portfolio

Follow En Rich Financial Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of En Rich Financial Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on En Rich Financial Partners LLC with notifications on news.